You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SEA-BCMA

Showing 1 - 25 of 304
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in United States (SEA-BCMA, dexamethasone, pomalidomide)

Recruiting
  • Multiple Myeloma
  • SEA-BCMA
  • +2 more
  • Palo Alto, California
  • +10 more
Aug 24, 2022

Multiple Myeloma, Multiple Myeloma in Relapse, Refractory Multiple Myeloma Trial in United States (ACTR087, SEA-BCMA)

Terminated
  • Multiple Myeloma
  • +2 more
  • ACTR087
  • SEA-BCMA
  • Phoenix, Arizona
  • +6 more
Mar 27, 2020

Multiple Myeloma Trial in United States (Talquetamab)

Recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +6 more
Sep 27, 2023

Immunotherapy, Multiple Myeloma Trial in Zhengzhou (Chimeric Antigen Receptor NK Cell Injection Targeting BCMA (BCMA CAR-NK))

Recruiting
  • Immunotherapy
  • Multiple Myeloma
  • Chimeric Antigen Receptor NK Cell Injection Targeting BCMA (BCMA CAR-NK)
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Dec 14, 2022

Multiple Myeloma Trial in Shanghai, Wenzhou (Human BCMA Targeted T Cells Injection)

Recruiting
  • Multiple Myeloma
  • Human BCMA Targeted T Cells Injection
  • Shanghai, Shanghai, China
  • +1 more
Dec 7, 2022

NSCLC, Gastric Carcinoma, Gastroesophageal Junction Carcinoma Trial in Worldwide (SEA-TGT, sasanlimab)

Recruiting
  • Non-small Cell Lung Cancer
  • +11 more
  • Birmingham, Alabama
  • +32 more
Jan 4, 2023

Multiple Myeloma Trial in Beijing, Guangzhou, Shanghai (TQB2934 injection)

Not yet recruiting
  • Multiple Myeloma
  • TQB2934 injection
  • Beijing, Beijing, China
  • +2 more
Dec 8, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Seattle (biological, drug, procedure)

Completed
Has Results
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 3, 2022

Gene Transcription and Immunophenotypes Following Mepolizumab

Active, not recruiting
  • Eosinophilic Asthma
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 17, 2023

    Multiple Myeloma Trial in Xuzhou (anti-BCMA/GPRC5D CAR-T CELL)

    Recruiting
    • Multiple Myeloma
    • anti-BCMA/GPRC5D CAR-T CELL
    • Xuzhou, Jiangsu, China
      Kailin Xu
    Aug 19, 2022

    Multiple Myeloma, Allogeneic Stem Cell Transplantation Trial in Spain (CARTemis-1)

    Not yet recruiting
    • Multiple Myeloma
    • Allogeneic Stem Cell Transplantation
    • CARTemis-1
    • Santander, Cantabria, Spain
    • +4 more
    Aug 1, 2023

    Multiple Myeloma Trial (BCMA CAR T cells, BCMA/CD19 CAR T cells)

    Enrolling by invitation
    • Multiple Myeloma
    • BCMA CAR T cells
    • BCMA/CD19 CAR T cells
    • London, County (optional), United Kingdom
      University College London Hospital
    Sep 15, 2022

    Multiple Myeloma, New Diagnosis Tumor Trial in Hangzhou (BCMA CAR-T cells)

    Recruiting
    • Multiple Myeloma
    • New Diagnosis Tumor
    • BCMA CAR-T cells
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital, College of Medicine, Zhejiang Uni
    Jan 31, 2023

    Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Los Angeles (procedure, drug, other)

    Not yet recruiting
    • Recurrent Multiple Myeloma
    • Refractory Multiple Myeloma
    • Bone Marrow Aspiration
    • +10 more
    • Los Angeles, California
      Melanie Ayala Ceja
    Jul 10, 2023

    Plasma Cell Leukemia Trial in Tianjin (anti-BCMA CAR-T, VRD-based regimen)

    Recruiting
    • Plasma Cell Leukemia
    • anti-BCMA CAR-T
    • VRD-based regimen
    • Tianjin, China
      Institute of Hematology and Blood Diseases Hospital Chinese Acad
    Aug 4, 2023

    Relapsed/ Refractory Multiple Myeloma Trial (GC012F)

    Not yet recruiting
    • Relapsed/ Refractory Multiple Myeloma
    • GC012F
    • (no location specified)
    Apr 28, 2023

    Multiple Myeloma Trial in Wuhan (Fludarabine + Cyclophosphamide + BCMA-GPRC5D CAR-T Cells)

    Recruiting
    • Multiple Myeloma
    • Fludarabine + Cyclophosphamide + BCMA-GPRC5D CAR-T Cells
    • Wuhan, Hubei, China
      Union Hospital, Tongji Medical College, Huazhong University of S
    Aug 11, 2023

    Relapsed/Refractory Diffuse Large B-cell Lymphoma and Multiples Myeloma Trial in Dresden (MDC-CAR-BCMA001 (BCMA directed CAR

    Not yet recruiting
    • Relapsed/Refractory Diffuse Large B-cell Lymphoma and Multiples Myeloma
    • MDC-CAR-BCMA001 (BCMA directed CAR T-cells)
    • Dresden, Germany
      Technische Universität Dresden, NCT/UCC, Early Clinical Trial Un
    Apr 19, 2023

    Multiple Myeloma Trial in Tianjin (anti-BCMA CAR-T, VRD)

    Recruiting
    • Multiple Myeloma
    • anti-BCMA CAR-T
    • VRD
    • Tianjin, China
      Institute of Hematology and Blood Diseases Hospital Chinese Acad
    May 5, 2023

    CAR-T Cell Therapy Trial in Shanghai (GC012F injection)

    Recruiting
    • CAR-T Cell Therapy
    • GC012F injection
    • Shanghai, Shanghai, China
      Department of Rheumatology, Ren Ji Hospital South Campus, School
    May 5, 2023

    CAR-T Trial in Hangzhou (GC012F injection)

    Recruiting
    • CAR-T
    • GC012F injection
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital,College of Medicine, Zhejiang Univ
    May 10, 2023

    Pulmonary Vascular Disease, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zurich

    Active, not recruiting
    • Pulmonary Vascular Disease
    • +2 more
    • Assessment without intervention at High altitude
    • Relocation to sea level for 2 days
    • Zurich, Switzerland
      University Hospital Zurich
    Oct 2, 2023

    Multiple Myeloma Trial in Beijing, Suzhou (CAR-BCMA T Cells)

    Recruiting
    • Multiple Myeloma
    • CAR-BCMA T Cells
    • Beijing, Beijing, China
    • +1 more
    Jan 26, 2023

    Pulmonary Vascular Disease, Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zurich

    Active, not recruiting
    • Pulmonary Vascular Disease
    • +2 more
    • Relocation from HA to LA
    • Zurich, Switzerland
      Respiratory Clinic, University Hospital of Zurich
    Oct 17, 2023

    Pulmonary Vascular Disease, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zurich

    Recruiting
    • Pulmonary Vascular Disease
    • +2 more
    • Relocation to sea level
    • Zurich, Switzerland
      University Hospital Zurich
    Aug 9, 2023